On this page
A testosterone score labeled optimal, suboptimal, or age-adjusted is not by itself a diagnosis. The important question is whether a qualified clinician has established a recognized condition using appropriate evidence.
Look beyond one number
The Endocrine Society's guidance for diagnosing hypogonadism in men combines compatible symptoms and signs with consistently low, accurately measured testosterone. Its July 2026 statement reaffirms the need for clinical diagnosis and testing quality. Symptoms alone and an isolated result each leave important questions unanswered.
Confirmation and collection conditions matter. The clinician should determine the appropriate test and timing and whether additional evaluation is needed. Do not use an online chart to select a personal target or start a treatment plan independently.
Ask where the proposed target came from
A seller may present a preferred interval without explaining the population, assay, or evidence behind it. Ask whether the target is a laboratory reference interval, a diagnostic criterion, a treatment-monitoring target, or a marketing category. These terms are not interchangeable.
The Society does not generally support population-level screening for hypogonadism in asymptomatic men. That does not mean concerns should be ignored; it means testing should be connected to a clinical question rather than used as a universal performance score.
Keep diagnosis and treatment decisions distinct
Even when a finding warrants further assessment, the next step is not automatically testosterone therapy. The cause, potential benefits, risks, and individual circumstances require a professional discussion. A purchase package that moves directly from a score to a prescription or supplement offer may leave that reasoning unclear.
Bring the complete report and collection details to a qualified clinician, along with symptoms and a current medicine and supplement list. Ask what remains uncertain and what evidence would resolve it.
This article concerns the reasoning behind diagnosis in the population addressed by the cited guidance. It does not interpret personal values, cover every hormonal context, or provide dosing advice. We offer no hormone-testing or treatment purchase link.
Sources and further reading
Primary and contextual sources used to verify definitions or give readers a relevant next resource.
- Endocrine Society: Testosterone therapy guideline Diagnosis in men requires compatible findings and consistently low accurate measurements, with appropriate clinical confirmation.
- Endocrine Society: 2026 testosterone statement Reaffirms clinical diagnosis and testing quality; population screening of asymptomatic men is not generally supported.